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Background: Inhibition from GABAergic interneurons in brain circuits is a critical component of cognitive function.
This inhibition is regulated through a diverse network of neuromodulation. A number of recent studies suggest that
one of the major regulators of interneuron function is nicotinic acetylcholinergic transmission and dysregulation of
both systems is common in psychiatric conditions. However, how nicotinic modulation impacts specific subpopulations
of diverse GABAergic interneurons remains in question. One potential way of conferring specificity to the convergence
of GABAergic and nicotinic signaling is through the expression of a unique family of nicotinic acetycholine receptor
modulators, the Lynx family. The present study sought to identify members of the Lynx family enriched in cortical
interneurons and to elucidate subpopulations of GABAergic neurons that express unique nicotinic modulators.
Results: We utilize double fluorescence in situ hybridization to examine the interneuronal expression of the Lynx
family in adult mouse visual cortex. We find that two of the Lynx family members, Lynx1 and Lypd6, are enriched in
interneuron populations in cortex. Nearly all parvalbumin interneurons express Lynx1 but we did not detect Lypd6 in
this population. Conversely, in somatostatin interneurons Lypd6 was found in a subset localized to deep cortical layers
but no somatostatin neurons show detectable levels of Lynx1. Using a combination of genetic and viral manipulations
we further show that a subpopulation of deep-layer cortico-cortical long-range somatostatin neurons also express Lypd6.
Conclusions: This work shows that distinct subpopulations of GABAergic interneurons express unique Lynx family
members. The pattern of expression of Lynx family members within interneurons places them in a unique position to
potentially regulate the convergence of GABAergic and nicotinic systems, dysfunction of which are characteristic of
psychiatric disorders.
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GABAergic interneurons provide the major source of
inhibition to cortical networks. The proper functioning
of GABAergic circuits are critical for appropriate network
activity as animal models of dysfunctional GABAergic sig-
naling show deficits in cortical plasticity [1-5], a disruption
of normal synchronous oscillations [6,7] and cognitive def-
icits [6,8]; common hallmarks associated with psychiatric* Correspondence: hirofumi.morishita@mssm.edu
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article, unless otherwise stated.disorders such as Schizophrenia [6,9,10]. GABAergic inter-
neurons, however, are an extremely diverse population that
can be molecularly classified into three non-overlapping
groups based on the expression of either Parvalbumin
(PV), Somatostatin (SST) or serotonin receptor 3a (5-
HT3AR) that together encompass nearly 100% of all
cortical interneurons [11]. Particularly, deficits in both PV
and SST interneurons have been reported in the brains of
Schizophrenic patients upon post-mortem analysis [12-14],
and both PV and SST neurons have been implicated in
governing network oscillations in the brain [6,15]. Thus
the precise modulation of distinct interneuron populations
could have a significant impact on brain function and
disease.d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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onto GABAergic neurons is through nicotinic acetylcholi-
nergic signaling. Nicotinic signaling is pivotal to a number
of cognitive processes including attention and learning and
memory processes and is thought to contribute to syn-
chronous oscillatory activity [16-20]. Indeed, developmental
nicotinic dysfunction may contribute to neuropsychiatric
conditions including schizophrenia [21]. In the neocortex,
interneurons are the major target of basal forebrain derived
nicotinic signaling [22-24]. Among GABAergic subtypes,
this signaling is divergent, differentially expressed across
cortical lamina and driven through varying nicotinic acetyl-
choline receptor (nAChR) subunits [25,26]. However, the
manner in which tight regulation of GABAergic-nicotinic
convergence is achieved at the interneuronal subtype level
remains to be elucidated.
The recent discovery of the Lynx family provides a po-
tential new layer of modulation of nicotinic signaling. The
Lynx family is a member of the Ly-6/uPAR superfamily
which is characterized by a three-looped folding structure
or toxin fold due to a similarity to snake venom toxins
such as α-bungarotoxin. These toxin-like proteins can bind
to the extracellular face of nAChRs and ultimately aug-
ment signaling [27]. Recent evidence suggests that the
Lynx family may also impact nicotinic function by altering
assembly of receptors in the endoplasmic reticulum and
additionally may impact early embryogenesis through other
signaling pathway [28,29]. While many members of the
Lynx family are found in the periphery, only a handful have
been shown to be enriched in the mammalian brain
[27,30]. For the most part, members of the Lynx family are
thought to inhibit signaling through nicotinic receptors
potentially by interfering with ligand binding [31,32],
however, at least one member, Lypd6, acts to potentiate
calcium currents through nAChRs [33]. This differential
activity with respect to nAChR signaling could provide a
means for tight regulation of nicotinic tone in specific pop-
ulations of neurons. This tight regulation of nicotinic tone
may be important for a number of brain functions and
indeed Lynx family members have been associated with
regulation of plasticity in visual cortex, learning and mem-
ory functions, sensorimotor gating and anxiety related
behavior [32-36]. The importance of the Lynx family for
cognitive function is further highlighted by severe intellec-
tual disabilities displayed by patients with copy number
variants (CNVs) in Lynx family loci [37]. Alternations in
the expression of Lynx family members are also associated
with some mouse models of psychiatric and neurodegener-
ative disorders [27]. Taken together, these findings suggest
a critical role of the Lynx family in controlling nicotinic
tone for optimal cognitive function. However, little remains
known about the precise expression of Lynx family mem-
bers within the brain and specifically within interneuronal
populations.Here we sought to determine the specific expression of
Lynx family members with respect to GABAergic inter-
neuron populations. We utilize open access expression data
and double fluorescence in situ hybridization (DISH) to
screen members of the Lynx family for enrichment in inter-
neuron populations in mouse primary visual cortex (V1), a
model system where the role of Lynx1 in cortical plasticity
was previously established. We further characterize the
GABAergic expression of two members of the Lynx family,
Lynx1 and Lypd6, finding that they are expressed in
discrete interneuron subpopulations. This discrete inter-
neuronal expression of two Lynx family members makes
them ideal candidates to provide tight regulation upon the
convergence of GABAergic and nicotinic signaling.
Results
GABAergic interneurons express a subset of Lynx family
members, Lynx1 and Lypd6
We first sought to elucidate members of the Lynx family
that are expressed in GABAergic interneurons in mouse
V1. By utilizing the Allen Brain Atlas [38], we screened
for expression patterns of Lynx family members that
show a scattered expression mimicking the distribution
of GABAergic interneurons in the cortex and narrowed
them down to six members of the Lynx family expressed
in V1; Lynx1, Lypd6, Lypd6b, Lynx2, Ly6E and Ly6H.
Next, we determined the differential expression pattern
of these family members in GABAergic inhibitory neurons
and excitatory neurons in V1. We performed DISH of
each of the Lynx family members along with GAD65 or
vGlut1, mutually exclusive markers of GABAergic and
glutamatergic neurons respectively (Additional file 1:
Figure S1). Lynx1 is expressed throughout V1 with the
notable exception of layer 1. Deep cortical layers show
robust Lynx1 labeling in V1. Co-labeling of Lynx1 and
GAD65 mRNA revealed that Lynx1 is enriched in inter-
neurons (60 ± 7.86% of Lynx1+ cells express GAD65) but
is also expressed in a subpopulation of glutamatergic
neurons (28.933 ± 8.66% of Lynx1+ cells express vGlut1)
in V1 (Figure 1). The laminar expression of Lypd6 is far
more restricted to layer V/VI in V1. Similarly to Lynx1,
Lypd6 mRNA is enriched in GABAergic populations with
78% of Lypd6+ neurons expressing interneuron marker
GAD65. As is the case with Lynx1, Lypd6 mRNA is found
in a subset of glutamatergic neurons (28 ± 10.80% of
Lypd6+ cells express vGlut1) that make up the minority of
the Lypd6+ population (Figure 1). Lypd6b expression was
sparse and restricted to deep layers in adult V1. When
co-labeled with GAD65, Lypd6b showed more restricted
interneuronal expression (33.33 ± 5.43% of Lypd6b + cells
express GAD65). Instead, Lypd6b was primarily expressed
in layer 6 glutamatergic neurons as evidenced by a high
degree of overlap with vGlut1 (56.52 ± 2.886% of


















































Figure 1 Lynx family expression in GABAergic and glutamatergic populations in cortex. A) Representative images from coronal sections of
mouse primary visual cortex (V1) of double in situ hybridization labeling mRNA of GAD65 (red) and Lynx family members (green). Insets show
double labeling. B) Quantification of the percentage of cells expressing each Lynx family member that co-express GAD65. C) Double in situ
hybridization labeling mRNA of vGlut1 (red) and Lynx family members (green). Insets show double labeling. D) Quantification of the percentage
of cells expressing each Lynx family member that co-express vGlut1. Error bars represent S.E.M. from n = 3-4 mice. Scale bar = 100 μm.
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neurons. Nearly all Lynx2+ cells in V1 co-localized with
vGlut1 (92.45%) suggesting that the expression is nearly
exclusive to excitatory neuronal populations (Figure 1).
Finally, two additional Lynx family members, Ly6E and
Ly6H, showed robust V1 expression but, similarly to
Lynx2, were restricted to glutamatergic populations
showing no detectable overlap with GAD65 expression
in V1 (Additional file 1: Figure S2). Overall, the enrich-
ment of Lynx1 and Lypd6 in cortical GABAergic popu-
lations suggests that these two nicotinic modulators
may be well positioned to regulate nAChR signaling in
GABAergic interneurons.
5HT3AR interneurons do not show detectable levels of
Lynx1 and Lypd6
As both Lynx1 and Lypd6 were not expressed in all
GAD65 positive GABAergic interneurons but instead
smaller subpopulations (Lynx1 in 39.13% of GAD +cells, Lypd6 in 8.91% of GAD + cells: Additional file 1:
Figure S3), we next aimed to identify the specific subpop-
ulation of GABAergic interneurons expressing Lynx1 and
Lypd6. Recent work established that GABAergic popula-
tions could be further subclassified through the mutually
exclusive expression of one of three molecular hallmarks;
the calcium binding proteins Parvalbumin (PV) and Som-
atostatin (SST) as well as serotonin receptor 3a (5HT3AR),
which collectively cover 100% of GABAergic interneurons
[11]. We first examined whether Lynx1 and/or Lypd6 is
expressed in 5HT3AR + neurons in V1. 5HT3AR + neurons
are enriched in layer1 and highly responsive to nicotine.
DISH for Lynx1 and 5HT3AR or vasoactive intestinal pep-
tide (VIP), a marker for a subclass of nicotinic responsive
5HT3AR neurons, showed no detectable levels of Lynx1
co-localized with either marker (Figure 2). Likewise,
detectable levels of Lypd6 were not found to be expressed
on any 5HT3AR + or VIP + neurons (Figure 2). These re-




















Figure 2 5HT3AR interneurons do not show detectable
expression Lynx1 or Lypd6. Representative images of double in
situ hybridization labeling mRNA for 5HT3AR (red, top panels) or
vasoactive intestinal peptide (VIP)(red, bottom panels) with Lynx1 or
Lypd6 (green). Note that none of the cells labeled with either Lynx
family mRNA co-localize with 5HT3AR or VIP positive neurons as is
shown in the insets. Scale bar = 100 μm.
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however, the physiological function of any subthreshold
expression in these cells is likely to be more limited.
Mutually exclusive expression of Lynx1 and Lypd6 in PV
and SST interneurons
The negative expression of both Lynx1 and Lypd6 in
5HT3AR + neurons indicates that they must be expressed
on interneurons encompassing the other subclasses, PV
and SST. Therefore, we sought to determine the expres-
sion of Lynx1 and Lypd6 in these subpopulations. We first
investigated the expression of Lynx1 and Lypd6 in PV +
interneurons. DISH for PV and Lynx1 confirmed the pre-
vious reports indicating nearly 90% of PV + interneurons
express Lynx1 [36]. In contrast, DISH for PV and Lypd6
revealed no expression of Lypd6 in PV-cells (Additional
file 1: Figure S4). Within the Lynx1+ population, approxi-
mately 60% expressed PV (Figure 3B). Therefore, restricted
PV expression is consistent with the finding that ~60% of
Lynx1 neurons co-express GAD65 (Figure 1).
Next, to examine the expression of Lynx1 and Lypd6
in SST + interneurons, DISH for SST and Lynx1 or
Lypd6 were performed. In stark contrast to PV-cells,
SST + cells showed no expression of Lynx1, but did
express Lypd6. Nearly 70% of Lypd6 expressing neurons
in V1 were found to express SST (Figure 3A,B bottom).
Again, this is consistent with Lypd6 expression beingrestricted to the SST subtype of interneurons as 77% of
all Lypd6 expressing neurons express GAD65 (Figure 1).
The divergent and restricted expression of Lynx1 and
Lypd6 within GABAergic populations suggests a complex
regulation of nicotinic signaling. Within the local cortical
circuit, Lynx1 and Lypd6 each regulate nAchRs in a dis-
tinctive subtype of interneurons that may confer separate
functions or could converge on a unique circuit for highly
ordered control of nicotinic signaling.
Lypd6 is enriched in subsets of SST cortical interneurons
located in layer 5/6
Unlike the expression of Lynx1 in nearly all PV neurons,
Lypd6 expression is rather restricted to a subset of deep-
layer SST neurons in V1 comprising 19.7 ± 1.7% of the
total SST population (Additional file 1: Figure S5). As
SST neurons can be further molecularly subclassified
using the expression of calbindin (CB) and Neuropeptide
Y (NPY) [39], we sought to determine if Lypd6 expression
was restricted to a unique molecularly defined subtype of
SST neurons. Lypd6 is expressed in both CB and NPY ex-
pressing interneuron populations (Figure 4A,B). However,
the co-expression with these markers accounts for less
than 60% of total Lypd6 expression suggesting that Lypd6
is also expressed in SST cells that do not contain either
CB or NPY (Figure 4B). Furthermore, Lypd6 expression is
restricted to only a subset of each of these populations
(Figure 4C). Taken together, these results suggest that
Lypd6 does not localize discretely to a single currently
recognized subtype of SST neuron but could potentially
identify a unique molecular subtype of deep layer SST
neurons.
In general inhibitory neurons are thought to contribute
mainly to local circuit activity. However, GABAergic
projection neurons have been identified from a number of
structures (for review [40]). In the murine neocortex,
long-range cortico-cortical GABAergic neurons have been
identified and shown to express SST and NPY. A large
number of these inhibitory projection neurons arise from
deep cortical layers [41]. To examine the expression of
Lypd6 on long-range SST cortico-cortical neurons, we
combined genetic and viral approaches with DISH in vivo.
Specifically, we utilized SST-cre mice and cre-dependent
retrograde viral GFP labeling using AAV5-DIO-EGFP [42]
and performed DISH with probes designed to recognize
Lypd6 and GFP mRNA. Virus was injected into somato-
sensory cortex (S1) in order to retrogradely label SST
neurons projecting from V1 to S1 where long-range SST
neurons have been previously reported (Figure 4D) [41].
Retrograde GFP labeling of SST neurons was sparse in V1
and mainly localized to deep cortical layers. The GFP
labeled SST projection neurons only represented a small
minority of the total V1 SST population. However, it is





























Figure 3 Parvalbumin and somatostatin interneurons express distinct Lynx family members. A) Representative images of visual cortex
sections stained via double in situ hybridization with probes directed against markers of two interneuronal subtypes, PV (red, top panels) and SST
(red, bottom panels), along with either Lynx1 (green, left panels) or Lypd6 (green, right panels). White arrowheads represent cells that show
co-localization of PV or SST with either Lynx or Lypd6. B) Quantification of the percentage of Lynx1+ (top) or Lypd6+ (bottom) cells that
co-localize with either PV or SST. *p <0.05 students t-test. Error bars represent S.E.M. of n = 3-4 mice. Scale bar = 50 μm.
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range SST neurons is likely underestimated by simple S1
retrograde labeling. Intriguingly, we find that a subset of
the cortico-cortical SST neurons co-localize with Lypd6
(Figure 4E). With respect to the Lypd6+ population, only
a small percentage expressed GFP and thus represent V1
to S1 projection interneurons. Again, it is possible that
Lypd6 expressing cortico-cortical SST neurons project to
other regions as well and may represent a larger total pro-
portion than in the present experiment. These findings
represent the first evidence of a potential involvement of
nicotinic signaling in cortico-cortical inhibitory neurons
and opens the door to new research into the functional
role of SST long-range circuits and their modulation by
nicotinic signaling.Discussion
In the present study we screened members of the Lynx
family of nicotinic receptor modulators for GABAergic
expression using in situ hybridization. We found that
two members of the Lynx family, Lynx1 and Lypd6, were
highly enriched in GABAergic interneuronal populations
in visual cortex. Intriguingly, within GABAergic subtypes,
Lynx1 is only expressed on PV + neurons while Lypd6 isrestricted to SST + interneurons. Further, a subset of Lypd6
expressing neurons was found to be cortico-cortical
long-range interneurons through retrograde viral label-
ing coupled with in situ hybridization.
One of the major findings of this study is the specific
expression of Lynx1 in most PV interneurons but not in
other subtypes of interneurons. Lynx1 has been shown
to bind to nAchRs such as the homomeric α7 subunit
and heteromeric α4β2 containing receptors to decrease
the response to acetylcholine [31]. The response of cor-
tical fast-spiking, putative PV interneurons, to acetylcho-
line could be blocked by addition of MLA, an α7
antagonist, or through genetic ablation of the α7 subunit
but were unaffected by the non-α7 antagonist, DHβE [26].
Additionally, α7-null mice show decreased cortical levels
of PV [43]. Taken together, these results suggest a role for
homomeric α7 nAchRs in cortical PV neurons and poten-
tial modulation of these receptors by Lynx1 in PV inter-
neurons. One potential functional implication of this
modulation is the regulation of cortical plasticity. Utilizing
ocular dominance (OD) plasticity in the visual cortex as a
model, it was shown that Lynx1 acts as a brake molecule,
limiting plasticity in adult V1 via increased expression
[36]. The control of Lynx family expression appears to
be complex and has not been fully elucidated, however,
Figure 4 Lypd6 is expressed in a unique subpopulation of somatostatin interneurons. A) Representative images from double in situ
hybridization of coronal sections of primary visual cortex labeled with probes directed against Lypd6 (green) and molecular markers of
somatostatin subtypes neuropeptide Y or calbindin (red). B) Quantification of the percentage of total Lypd6+ neurons that co-express either
neuropeptide Y or calbindin. C) Quantification of the percentage of each SST subtype marker (NPY or CB) that co-express Lypd6. D) Schematic
representation of viral labeling of long-range SST neurons. E) Representative image of DISH for GFP and Lypd6 mRNA in V1 of SST-cre mice
injected with retrograde cre-dependent GFP in S1. Arrowhead shows double labeled long-range SST neuron. Inset represents high-magnification
(63×) image of double labeling. Low and high magnification = 100 μm and 15 μm respectively.
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manipulations [44], in response to cholinergic perturbation
[45,46] and under sensory conditions [35]. Our results
showing an enrichment of Lynx1 specifically in PV neu-
rons, but not other GABAergic subtypes, in V1 suggests
that the function of Lynx1 on cortical plasticity could be at
least in part mediated through PV neurons. PV neurons
have been implicated in OD plasticity as the disruption of
perineuronal nets surrounding PV neurons can activate
OD plasticity in adults [47]. To this point, a recent study
showed that pharmacogenetic inhibition of PV neurons
for 1 day following monocular deprivation could re-
activate OD plasticity in the adult [48]. This suggests
that PV neurons play an instructive role in OD plasti-
city and that Lynx1 could act through modulation of
nAChRs in PV neurons to suppress OD plasticity in
adulthood when Lynx1 expression is elevated.
Additionally, Lynx1 could play a role in governing the
synchronized network oscillations in the brain thatunderlie many cognitive functions. PV interneurons are
thought to play a role in controlling the synchrony of net-
work gamma oscillations in the brain. The activity of PV +
basket cells is strongly coupled with gamma network oscil-
lations in the hippocampus [49] and optogenetic
disruption of PV cell activity can abolish gamma rhythm
activity in cortical circuits [50]. Interestingly, α7
nAChRs have also been implicated in the control of
gamma oscillations [51]. Network gamma oscillations
have been strongly correlated with cognitive activity
including working memory [52,53] and sensorimotor
gating both of which represent common endopheno-
types of psychiatric disorders including schizophrenia
[31,51,52]. Both PV dysfunction in schizophrenia [54]
as well as microdeletion of human 15q13.3, which in-
cludes the loss of the α7 nAChR gene and is linked
with cognitive disorders such as schizophrenia, autism
and mental retardation [55], have been associated with
underlying disturbance of gamma oscillations. Indeed,
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PV deficits [43] and mice genetically modified to
mimic the human 15q13.3 microdeletion show dys-
functional gamma oscillatory activity [56] suggesting
a potential convergence of α7 nAChR and PV cen-
tered mechanisms in cognitive function and psychi-
atric disorders where Lynx1 is well positioned to
mediate these functions. Of note, a mouse model of
22q11 microledetion syndrome, a genetic lesion asso-
ciated with increased risk of ADHD, autism spectrum
disorders, schizophrenia, and other psychiatric condi-
tions, showed significantly reduced Lynx1 expression
in prefrontal cortex [57].
In addition to Lynx1 expression on PV + interneurons,
we find that a separate member of the Lynx family,
Lypd6 is enriched in a population of deep layer SST in-
terneurons without expression on any other GABAergic
subtype. Most cortical SST interneurons are Martinotti
cells which send their axons into superficial layers where
they form dense axon collateral networks in layer I [58].
Little is known about the nicotinic responsiveness of
specific cortical SST subpopulations, however, Martinotti
cells are morphologically and physiologically similar to
oriens-lacunosum moleculare (O-LM) neurons of the
hippocampus [59] that have been shown to be highly
responsive to nicotinic signaling [60,61] and also densely
express Lypd6 (Additional file 1: Figure S5). Nicotinic
activation of O-LM neurons in CA1 facilitates long term
potentiation through increases in calcium influx [61,62].
The activation or potentiation of O-LM neurons as well
as neurons in the central amygdala is required for cer-
tain forms of experience dependent fear learning [63,64].
Lypd6 is an ideal candidate to mediate or modulate
these activities through its ability to directly potentiate
calcium currents through nicotinic receptors [33]. In
cortical circuits, little is known about the involvement of
SST neurons in experience-dependent plasticity but their
positioning within cortical circuits make them an intri-
guing candidate to govern OD plasticity where the ex-
pression of Lypd6 could modulate any impact that they
have. SST neurons highly innervate local PV cells placing
them in an ideal position to drive the inhibition instructive
to plasticity [48,65-67]. Additionally, SST neurons may dir-
ectly mediate plasticity mechanisms through the inhibition
of incoming information to the distal dendrites of pyr-
amidal neurons [68,69]. These observations highlight
the importance of future work designed to elucidate
the role of SST neurons in OD plasticity and how these
functions may be mediated by molecular modulators
such as Lypd6.
Somatostatin interneurons, much like PV neurons, play
a pivotal role in shaping rhythmic oscillatory activity.
However, SST cells fire rhythmically in the theta frequency
to help shape cortical theta rhythms [15]. Theta rhythmsare linked to spatial exploration, REM sleep, memory and
information packaging [70]. Patients with Schizophrenia
have been reported to have a decrease in SST neurons
and mRNA [71,72] as well as an increase in rhythmic
theta activity [73]. Nicotine can actively induce rhythmic
theta activity in the hippocampus through a GABA medi-
ated mechanism suggesting a convergence of the two
systems where Lypd6 may act in a modulatory role to gate
the formation of rhythmic activity [74]. This could also
help to explain the impact of Lypd6 over-expression on
cognitive processes as well as the cognitive deficits in pa-
tients with CNVs in the Lypd6 locus [33,37]. We further
find that a subset of long-range cortico-cortical SST
neurons projecting from visual to somatosensory cor-
tex express Lypd6. While the presence of long-range
SST neurons in cortex has been previously reported
[41], our study is the first to provide evidence that
these neurons may be modulated by nicotinic signal-
ing. While the long-range circuit in cortex has not
been well established, it is believed that cortico-cortical
SST neurons preferentially target glutamatergic neurons
[75]. The functional significance of these circuits has
also remained elusive. However, due to the role of
GABAergic interneurons as pace-makers of rhythmic activ-
ity, it has been postulated that long-range GABAergic neu-
rons may serve to control the interregional synchronization
of network frequencies and that deficiencies in these cir-
cuits could contribute to psychiatric dysfunction [40,76].
Conclusion
The convergence of GABAergic and nicotinic signaling
plays a pivotal role in brain plasticity and cognitive func-
tions, and dysregulation of this convergence could contrib-
ute to psychiatric conditions. Here we present evidence
that some members of the Lynx family of nicotinic modula-
tors are expressed preferentially on interneurons where
they could be integral to regulating this convergence. Fur-
ther, the expression of the Lynx family members on distinct
interneuron subpopulations could confer intricate specifi-
city to nicotinic regulation. This has potential significance
for understanding the circuit basis of cognitive functions
and for developing strategies designed to specifically target
interneuron subpopulations that could produce therapeu-
tics for psychiatric conditions that function more specific-
ally and avoid adverse effects often associated with
neuropsychiatric drugs. Direct examination of expression
profiles of Lynx family members in patient samples of ad-
dictive and psychiatric disorders will be also an important
area of future exploration.
Methods
Animals & brain processing
C57Bl/6 or somatostatin-ires-cre (SST-cre: Jackson labora-
tory #013044) mice were group housed under a standard
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7:00 PM) with constant temperature (23°C) and ad libitum
access to food and water. All animal protocols were ap-
proved by IACUC at Icahn School of Medicine at Mount
Sinai. For in situ hybridization experiments, mice were
anesthetized with isofluorane and cervically dislocated. The
brain was removed under RNAse free conditions and
briefly washed x2 in sterile 0.9% NaCl. Subsequently,
the brain was quickly frozen in a standard mold with
TissueTek O.C.T. (Sakura Finetek, Torrance, CA) in a
chamber of 2-methylbutane on dry ice. After freezing,
brains were transferred to −80°C until sectioning. Sectioning
was performed on a Leica CM3050 S cryostat (Leica Micro-
systems, Buffalo Grove, IL) at a thickness of 7 μm and sec-
tions were immediately placed onto Tissue Path Superfrost
Gold Plus slides (Fisher Scientific, Waltham, MA). Sections
were allowed to dry and then stored in slide boxes at −80°C.
Probe making
RNA probes for GAD65, PV, SST, CB were generated
using plasmids containing cDNAs gifted by Dr. Takashi
Kitsukawa (Osaka University). Cloning for developing
other RNA probes for in situ hybridization was performed
in a PBluescript II SK (−) vector using a PCR based iso-
thermal DNA assembly method. Briefly, primers were de-
signed to linearize the vector and create non-overlapping
overhang sequences. A second set of primers was utilized
to amplify the gene of interest from cDNA derived from
mouse cortex and create overhangs that were antisense to
the vector overhang sequences. Assembly was achieved
using Gibson Assembly master mix (New England
Biolabs) and the resulting vector was used to transform
NEB-5 (New England Biolabs) competent cells. Positive
(white) colonies were picked and cultured for miniprep.
All miniprep DNA was subjected to restriction digest
using xba1 and xho1 enzymes (New England Biolabs)
and examined for insert by gel electrophoresis. Properly
inserted colonies were then amplified by 50 ml culture
and subsequent midiprep using a Hispeed plasmid Midi
kit (Qiagen). Plasmid DNA was then linearized using
xho1 restriction digest and purified via phenol-chloroform
and ethanol precipitation. Probes were synthesized
using T3 RNA polymerase (Roche) and labeled with
either fluorescein or digoxigenin (Roche) for double in
situ hybridization.
























PBluescript II SK (−) forward: ATTCCTGCAGCCC
GGGG



















TCCATGCCGADouble fluorescence in situ hybridization
Frozen sections were thawed and fixed in 4% parafor-
maldehyde. Following fixation slides were washed in PBS
and incubated for 10 minutes in acetylation buffer (0.2%
HCl, 1.5% Triethanolamine, 0.28% acetic anhydride).
Slide were again washed in PBS and then acclimated to
hybridization buffer (50% formamide, 5× SSC, 2.5% yeast
tRNA, 5% Salmon sperm DNA, 10% denhardt’s solution)
in a humidity chamber. Following acclimation, the buffer
was replaced with new hybridization buffer containing
RNA probes and incubated overnight at 72°C in the humid-
ity chamber. The next day, slides were washed 3 × 30
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(TBS with 0.05% Tween 20 and 1% milk). Slides were then
incubated with milk containing anti-fluorescein POD
antibodies (1:2000) for 2 hours at room temperature.
Following incubation, slides were washed and sub-
jected to TSA Plus DNP signal amplification (Perkin
Elmer) and again washed. Next, slides were again
blocked with milk solution and incubated in milk so-
lution containing anti-DIG-akaline phosphatase and
anti-DNP-KLH-488 (both 1:1000, Roche) for 2 hours
at room temperature. Following incubation, slides
were washed and acclimated to TBS pH 8.0 and then
incubated in fast red solution (Roche) for 1 hour at
room temperature. Finally, slides were washed in
water and coverslipped using CC mount solution
(Sigma Aldrich).Image and statistical analyses
Imaging was performed using either an AX10 axio-
phot or LSM780 confocal microscope (Zeiss). Total
cell numbers were calculated for each channel using
ImageJ and setting a threshold equal to 3 times the
SD of the total cortex mean intensity and perform-
ing a loose size exclusion (10–100 μm). For the
quantification of co-localized cells, a color-based
threshold was applied using WCIF ImageJ (Wright
Cell Imaging Facility) to eliminate pure green and
red signal and a subsequent threshold and size exclu-
sion was performed. To determine the percentage of co-
localization, the total number of cells in a single channel
was divided by the number of co-localized cells. This ana-
lysis was done for 3–4 images/animal from 3–4 separate
mice. The averages are taken from the average co-
localization of each mouse and presented as mean ± SEM.
Where indicated, student’s t-test was performed using
Graphpad Prism (Graphpad) software to determine statis-
tical significance.Viral injection
Somatostatin-cre mice were isoflurane anesthetized
and head-fixed in a mouse steortaxic apparatus (Nar-
ishige). A mid-line incision was made in the scalp
and a micro-drill was used to drill a small hole in
the skull over the somatosensory cortex (S1). Two
injections of AAV5-syn-DIO-EGFP 500 μl each were
made (from Bregma AP: 2.0, ML: 2.75, DV: 0.45;
AP: 1.5, ML: 2.75, DV: 0.45) using a 2.5 μl Hamilton
syringe and microinjector set to inject at 200 nl/minute.
The syringe was left in place for 1 minute following the in-
jection to reduce backflow of virus. Mice were sutured
and allowed to recover from anesthesia in an empty cage
over a warming pad. Following recovery, mice were
returned to their home cage and allowed to maintain for4 weeks to allow for viral expression before euthanasia for
in situ hybridization.
Additional file
Additional file 1: Figure S1. GAD65 and vGlut1 probes label mutually
exclusive populations in V1. A representative image of a coronal section
through mouse primary visual cortex showing GAD65 (red) and vGlut1
(green) mRNA labeling using double in situ hybridization. Scale bar = 100 μm.
Figure S2. GABAergic interneurons do not show detectable Ly6E or Ly6H.
Representative images of coronal sections through primary visual cortex
showing double in situ hybridization labeling of vGlut1 (top panels) and
GAD65 (bottom panels) mRNA with mRNA for Lynx family members Ly6E
(left panels) and Ly6H (right panels). Note that neither Ly6E or Ly6H co-
localize with GAD65. Scale bar = 100 μm. Figure S3. Only a subpopulation of
GABAergic interneurons express Lynx1 and Lypd6. Quantification from
double in situ hybridization of the percentage of GAD65+ interneurons that
co-express either Lynx1 or Lypd6. Error bars represent S.E.M. of n = 3-4 mice.
Figure S4. The majority of PV + neurons express Lynx1 but only a
subpopulation of SST + neurons express Lypd6. Representative images
showing mRNA double labeling of PV (top) and SST (bottom) along with
either Lynx1 (left) or Lypd6 (right). Quantification of the percentage sof PV +
interneurons that co-express Lynx1and Lypd6 (top graph) or SST +
interneurons that co-express Lynx1 and Lypd6 (bottom graph). Error bars
represent S.E.M. of n = 3-4 mice. Scale bar = 100 μm. Figure S5.
Somatostatin positive Oriens-Lacunosum Moleculare neurons in CA1 express
Lypd6. Representative images from coronal sections of DISH with probes
directed against somatostatin (red) and Lypd6 (green) mRNA. Note the high
overlap between somatostatin O-LM neurons and Lypd6. Scale bar = 100 μm.
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